Endpoint definition
↥| Name | CD2_INSITU_MELANOMA_FACE |
|---|---|
| Long name | Melanoma in situ of other and unspecified parts of face |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Melanoma in situ of other and unspecified parts of face
melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 118 | 64 | 54 |
| Unadjusted prevalence (%) | 0.05 | 0.05 | 0.06 |
| Mean age at first event (years) | 70.46 | 69.06 | 72.12 |
| Case fatality at 5-years (%) | 1.69 | 0.00 | 3.70 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 38.14 | 42.19 | 33.33 |
Survival analyses between endpoints
↥Plot
before Melanoma in situ of other and unspecified parts of face
after Melanoma in situ of other and unspecified parts of face
Loading survival analyses plot…
Table
Loading survival analyses table…